ArticleAnnals of surgical oncology2026

Nationwide Implementation of Neoadjuvant Nivolumab-Based Chemo-Immunotherapy for Resectable NSCLC: Surgical Outcomes from a Prospective Multicenter Study.

Jiri Vachtenheim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.